Branded drugs play a crucial role in healthcare by treating various diseases and conditions, from chronic ailments to acute disorders. In the United States, the pharmaceutical industry is one of the most significant contributors to healthcare, with numerous drugs becoming household names due to their efficacy and wide usage. This article explores the top 10 branded drugs in the USA, examining their uses, market impact, and how they have transformed the lives of millions of patients.
Top 10 Branded Drugs in the USA
1. Humira (Adalimumab)
Humira, developed by AbbVie, is one of the top-selling drugs in the world and remains a leading medication in the United States. It is an anti-inflammatory biologic drug used to treat autoimmune conditions.
Uses:
Humira is primarily prescribed for conditions such as rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, ulcerative colitis, and ankylosing spondylitis. It works by inhibiting tumor necrosis factor (TNF), a substance that causes inflammation in the body.
Why It Stands Out:
Humira’s success is largely attributed to its wide range of applications in treating several autoimmune diseases. Its biologic nature offers targeted treatment, which has improved the quality of life for patients suffering from chronic inflammation and immune system disorders.
Market Impact:
Humira has been a blockbuster drug for AbbVie, generating billions in revenue annually. Despite facing biosimilar competition, it continues to be a dominant player in the biologic drug market.
2. Eliquis (Apixaban)
Eliquis, co-developed by Bristol-Myers Squibb and Pfizer, is a blood thinner used to reduce the risk of stroke and blood clots in people with atrial fibrillation, deep vein thrombosis (DVT), and pulmonary embolism (PE).
Uses:
Eliquis is an anticoagulant that works by blocking Factor Xa, a protein in the blood that is necessary for clotting. It is commonly prescribed for patients with non-valvular atrial fibrillation and those at risk of DVT or PE, especially following surgery.
Why It Stands Out:
Unlike older anticoagulants like warfarin, Eliquis does not require routine blood tests or dietary restrictions. This convenience, combined with its proven efficacy, makes it a preferred choice for many physicians and patients.
Market Impact:
Eliquis has become one of the top-selling drugs in the cardiovascular market, significantly outperforming other anticoagulants like Xarelto and Pradaxa.
3. Keytruda (Pembrolizumab)
Keytruda, developed by Merck, is an immunotherapy drug used to treat various cancers. It works by enabling the immune system to detect and fight cancer cells.
Uses:
Keytruda is used to treat melanoma, non-small cell lung cancer, head and neck squamous cell carcinoma, classical Hodgkin lymphoma, and other cancers. It is part of a class of drugs called PD-1 inhibitors, which block the PD-1 protein on T cells from binding with PD-L1 on cancer cells, allowing the immune system to attack tumors.
Why It Stands Out:
Keytruda has revolutionized cancer treatment by offering a new approach to managing the disease. Its ability to provide durable responses in cancers that were once considered difficult to treat has made it a breakthrough therapy in oncology.
Market Impact:
Keytruda has generated significant revenue for Merck and has become a leader in the immuno-oncology space, helping to shape the future of cancer treatment.
See Also: 10 Best States to Live in the USA for Families
4. Revlimid (Lenalidomide)
Revlimid, developed by Celgene (now part of Bristol-Myers Squibb), is an oral cancer drug used to treat multiple myeloma, a type of blood cancer. It is also used for certain types of lymphoma and anemia.
Uses:
Revlimid is an immunomodulatory drug that enhances the immune system’s ability to attack cancer cells. It is commonly prescribed in combination with other medications to treat multiple myeloma and myelodysplastic syndromes (MDS).
Why It Stands Out:
Revlimid has transformed the treatment landscape for multiple myeloma patients, offering longer remission periods and improving survival rates. It remains one of the most important drugs in the hematology-oncology field.
Market Impact:
Despite its high cost, Revlimid continues to be a top-seller in oncology, generating billions of dollars annually for Bristol-Myers Squibb.
5. Januvia (Sitagliptin)
Januvia, developed by Merck, is an oral medication used to treat type 2 diabetes. It belongs to a class of drugs called DPP-4 inhibitors, which help regulate blood sugar levels.
Uses:
Januvia works by increasing the levels of incretin hormones, which help control blood sugar by stimulating insulin release and reducing the amount of glucose produced by the liver. It is typically prescribed alongside diet and exercise for type 2 diabetes management.
Why It Stands Out:
Januvia is favored for its efficacy in lowering blood sugar without causing weight gain or severe hypoglycemia, side effects that are common with other diabetes medications.
Market Impact:
As a leading drug in the diabetes market, Januvia has been a major contributor to Merck’s revenues, particularly in the United States, where diabetes prevalence continues to rise.
6. Enbrel (Etanercept)
Enbrel, co-developed by Amgen and Pfizer, is a biologic drug used to treat autoimmune conditions, including rheumatoid arthritis, psoriatic arthritis, and plaque psoriasis.
Uses:
Enbrel is a TNF inhibitor that works by reducing inflammation and slowing the progression of disease in patients with autoimmune disorders. It is commonly prescribed for adults with rheumatoid arthritis and children with juvenile idiopathic arthritis.
Why It Stands Out:
Enbrel was one of the first biologic drugs to treat autoimmune diseases effectively, and it has helped improve the lives of millions of patients with chronic inflammatory conditions.
Market Impact:
Enbrel has been a blockbuster drug for over two decades, generating billions in revenue for Amgen and Pfizer, although it faces increasing competition from biosimilars.
7. Xarelto (Rivaroxaban)
Xarelto, developed by Bayer and marketed by Janssen Pharmaceuticals in the United States, is an anticoagulant used to prevent and treat blood clots. It is commonly prescribed for patients with atrial fibrillation, DVT, or PE.
Uses:
Xarelto works by inhibiting Factor Xa, which is crucial in the blood clotting process. It is prescribed to reduce the risk of stroke in patients with non-valvular atrial fibrillation and to treat DVT and PE.
Why It Stands Out:
Xarelto’s once-daily dosing and lack of need for routine blood monitoring make it a convenient alternative to traditional blood thinners like warfarin. Its wide range of approved uses has made it a leading anticoagulant.
Market Impact:
Xarelto has become a top-seller in the cardiovascular drug market, providing strong competition to other blood thinners like Eliquis.
See Also: Top 10 Best Car Brands in the USA
8. Opdivo (Nivolumab)
Opdivo, developed by Bristol-Myers Squibb, is an immunotherapy drug used to treat various cancers, including melanoma, lung cancer, and kidney cancer. It belongs to a class of drugs known as PD-1 inhibitors.
Uses:
Opdivo works by blocking the PD-1 protein on T cells, which allows the immune system to detect and destroy cancer cells more effectively. It is used as a monotherapy or in combination with other cancer treatments.
Why It Stands Out:
Like Keytruda, Opdivo has been instrumental in advancing cancer immunotherapy. Its effectiveness in treating multiple types of cancer, including those that are difficult to treat, makes it a key player in oncology.
Market Impact:
Opdivo is one of the leading immuno-oncology drugs in the world, driving significant revenue for Bristol-Myers Squibb and offering hope for patients with advanced cancer.
9. Symbicort (Budesonide/Formoterol)
Symbicort, developed by AstraZeneca, is a combination inhaler used to treat asthma and chronic obstructive pulmonary disease (COPD). It contains a corticosteroid (budesonide) and a long-acting beta-agonist (formoterol).
Uses:
Symbicort helps control and prevent symptoms of asthma and COPD, such as wheezing and shortness of breath. It works by reducing inflammation in the airways and relaxing muscles to improve breathing.
Why It Stands Out:
The dual-action approach of Symbicort, combining both anti-inflammatory and bronchodilating effects, makes it a powerful treatment option for patients with chronic respiratory conditions.
Market Impact:
Symbicort is one of the top-selling respiratory medications globally, helping millions of patients manage their asthma and COPD effectively.
10. Imbruvica (Ibrutinib)
Imbruvica, developed by Pharmacyclics (a subsidiary of AbbVie) and Janssen Biotech, is an oral medication used to treat certain types of blood cancers, including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).
Uses:
Imbruvica works by inhibiting a protein called Bruton’s tyrosine kinase (BTK), which plays a role in the survival and spread of cancer cells. It is commonly prescribed for patients with CLL, MCL, and Waldenström’s macroglobulinemia.
Why It Stands Out:
Imbruvica has transformed the treatment landscape for blood cancers, offering an effective oral therapy that improves survival rates and reduces the need for chemotherapy.
Market Impact:
Imbruvica is a top-selling oncology drug, generating substantial revenue for AbbVie and Janssen while improving the lives of patients with difficult-to-treat blood cancers.
Conclusion
The pharmaceutical industry in the United States is home to some of the most innovative and life-saving drugs in the world. These top 10 branded drugs represent advancements in the treatment of chronic and life-threatening conditions, offering hope and improved quality of life for millions of patients. As these drugs continue to evolve and new treatments emerge, they will remain at the forefront of modern medici
You Might Be Interested In:
